The company raised its full-year revenue guidance from a range of $58 billion to $61 billion to a range of $60 billion to $62 billion. The midpoint suggests a 35% increase in sales for the full year.

Some of the losses are down to pharma's broader problems: notably, President Trump's tariff and price-cut threats. But there ...

In a candid conversation, tennis legend Serena Williams sheds light on her experience with GLP-1 medication, revealing her journey towards body positivity and health. As a mother of two and a 23-time ...

Serena Williams is already feeling the pressure as the Sister of the Bride. During an appearance on the “ Today ” show ...

The drug, which is estimated to be taken by up to 750,000 people, is one of the country's most popular weight loss and ...